Nautilus Biotechnology, Inc.
NAUT
Revenue
0.00
0.000.00%
-Assets
259.70M
▼-13.04M▼-4.78%
3 Months ChangeLiabilities
36.27M
▼-1.20M▼-3.20%
3 Months ChangeFree Cash Flow
-16.91M
▼-3.70M▼-27.97%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 10-Q
ID: 0001808805-24-000072
2024-10-29
Form 8-K
ID: 0001808805-24-000070
2024-07-30
Form 10-Q
ID: 0001808805-24-000058
2024-07-30
Form 8-K
ID: 0001808805-24-000055
2024-06-13
Form 8-K
ID: 0001808805-24-000043
2024-04-30
Form 10-Q
ID: 0001808805-24-000041
2024-04-30
Form 8-K
ID: 0001808805-24-000038
2024-02-28
Form 8-K
ID: 0001628280-24-007395
2024-02-28
Form 8-K
ID: 0001808805-24-000004
2023-12-14
Form 8-K
ID: 0001808805-23-000084